Oncimmune Holdings plc announced that Dr Adam M Hill will be stepping down as Chief Executive Officer, and as a director of the Company. Adam will support Oncimmune in the short term by providing continuity in some of the Company's ongoing commercial efforts and supporting a transition of his responsibilities and relationships to the new CEO and other colleagues as appropriate. Pending the appointment of a permanent successor, the Board has appointed Ron Kirschner, the Company's General Counsel and Company Secretary, as acting CEO, and a director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23 GBX | -4.56% | 0.00% | -8.73% |
Feb. 29 | EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout | AN |
Feb. 29 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.73% | 21.39M | |
+5.48% | 71.19B | |
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+6.53% | 1.69B |
- Stock Market
- Equities
- ONC Stock
- News Oncimmune Holdings plc
- Oncimmune Holdings plc Announces Executive Changes